Intra-fraction errors and inter-fraction deformation during pancreas SBRT: Analysis and predictability of dose variations for upper gastrointestinal organs.
2/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
31 pancreatic cancer patients, treated at CyberKnife (CK) in 5 fractions prescribing 40 Gy/50 Gy to PTV/GTV, were considered.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
OAR deformation has larger effects, but constraints were still met in 45% of patients. EIV is a promising predictive parameter.
OpenAlex 토픽 ·
Radiation Dose and Imaging
Advanced Radiotherapy Techniques
Cardiac Imaging and Diagnostics
[PURPOSES] /Objectives.
APA
Mauro Loi, R. Doro, et al. (2026). Intra-fraction errors and inter-fraction deformation during pancreas SBRT: Analysis and predictability of dose variations for upper gastrointestinal organs.. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 219, 111525. https://doi.org/10.1016/j.radonc.2026.111525
MLA
Mauro Loi, et al.. "Intra-fraction errors and inter-fraction deformation during pancreas SBRT: Analysis and predictability of dose variations for upper gastrointestinal organs.." Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, vol. 219, 2026, pp. 111525.
PMID
41936944 ↗
Abstract 한글 요약
[PURPOSES] /Objectives. Effects on OAR doses of intra-fraction respiratory tracking errors and inter-fraction deformation were evaluated for pancreas SBRT and predictability in terms of target-to -OAR proximity investigated.
[MATERIALS] /Methods. 31 pancreatic cancer patients, treated at CyberKnife (CK) in 5 fractions prescribing 40 Gy/50 Gy to PTV/GTV, were considered. Plan optimization required for duodenum, stomach and bowel V35Gy < 0.5 cm. Target-to-OAR proximity was quantified by the expansion-intersection volume (EIV), computed on each planning CT as the intersection between the PTV expanded by 5 mm and duodenum, stomach and bowel. Treatments were delivered using CK real-time respiratory tracking. Tracking errors occurring during each fraction were computed using the system log-files. To simulate their effects on OAR doses, a perturbed plan was created modifying each beam coordinates by the corresponding errors. Inter-fraction OARs deformation was retrospectively evaluated on pre-fraction CT scans. Deformed OARs were contoured and planned doses re-calculated on the deformed anatomy. OAR constraints of perturbed plan and deformed anatomy were considered met at V35Gy < 1 cm. EIV thresholds were defined and their predictive accuracy evaluated.
[RESULTS] EIV values ranged from 0.54 to 28.11 cm. Tracking errors standard uncertainties ranged from 0.6 to 6.4 mm. For plans perturbed by tracking errors, OAR constraints were violated (V35Gy = 1.2 cm) in a single patient showing the largest EIV value (28.11 cm) and large tracking uncertainties (>5 mm). Doses recalculated on deformed OARs still fulfilled constraints for 14/31 patients. For the remaining 16 cases, V35Gy values up to 8.0 cm (median 2.0 cm) were observed. An EIV threshold of 3.5 cm showed 77% prediction accuracy.
[CONCLUSIONS] CK tracking errors have small effects on OAR doses, but they must be minimized for those patients with large EIV values. OAR deformation has larger effects, but constraints were still met in 45% of patients. EIV is a promising predictive parameter.
[MATERIALS] /Methods. 31 pancreatic cancer patients, treated at CyberKnife (CK) in 5 fractions prescribing 40 Gy/50 Gy to PTV/GTV, were considered. Plan optimization required for duodenum, stomach and bowel V35Gy < 0.5 cm. Target-to-OAR proximity was quantified by the expansion-intersection volume (EIV), computed on each planning CT as the intersection between the PTV expanded by 5 mm and duodenum, stomach and bowel. Treatments were delivered using CK real-time respiratory tracking. Tracking errors occurring during each fraction were computed using the system log-files. To simulate their effects on OAR doses, a perturbed plan was created modifying each beam coordinates by the corresponding errors. Inter-fraction OARs deformation was retrospectively evaluated on pre-fraction CT scans. Deformed OARs were contoured and planned doses re-calculated on the deformed anatomy. OAR constraints of perturbed plan and deformed anatomy were considered met at V35Gy < 1 cm. EIV thresholds were defined and their predictive accuracy evaluated.
[RESULTS] EIV values ranged from 0.54 to 28.11 cm. Tracking errors standard uncertainties ranged from 0.6 to 6.4 mm. For plans perturbed by tracking errors, OAR constraints were violated (V35Gy = 1.2 cm) in a single patient showing the largest EIV value (28.11 cm) and large tracking uncertainties (>5 mm). Doses recalculated on deformed OARs still fulfilled constraints for 14/31 patients. For the remaining 16 cases, V35Gy values up to 8.0 cm (median 2.0 cm) were observed. An EIV threshold of 3.5 cm showed 77% prediction accuracy.
[CONCLUSIONS] CK tracking errors have small effects on OAR doses, but they must be minimized for those patients with large EIV values. OAR deformation has larger effects, but constraints were still met in 45% of patients. EIV is a promising predictive parameter.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (1)
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- The emerging implications of GLP-1 receptor agonists in radiation therapy.
- An automated method to establish patient specific asymmetric intrafraction motion monitoring tolerances for prostate radiotherapy.
- The impact of bladder and rectal dynamics on prostate and seminal vesicles intrafraction motion and deformation in radiotherapy.
- Magnetic resonance-guided simultaneous multi-focal adaptive radiotherapy for prostate, pElvis & metastases (MRgSMART-PEM) in prostate cancer: a prospective phase II study.
- Salvage stereotactic MR-Guided adaptive radiotherapy (SMART) re-irradiation for locally recurrent prostate Cancer: Clinical and dosimetric outcomes.
- Evaluation of hybrid DIR performance using controlling structures and points of interest in MR-guided adaptive radiotherapy for prostate cancer patients.